|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C12P 21/08 | |||
| C07K 16/40 |
| (11) | Patento numeris | 2608809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11820759.6 |
| Europos patento paraiškos padavimo data | 2011-08-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-07-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/049448 |
| Data | 2011-08-26 |
| (87) | Numeris | WO 2012/027721 |
| Data | 2012-03-01 |
| (30) | Numeris | Data | Šalis |
| 377886 P | 2010-08-27 | US |
| (72) |
MCCAULEY, Scott Alan, US
VAYSBERG, Maria, US
|
| (73) |
Gilead Biologics, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ANTIBODIES TO MATRIX METALLOPROTEINASE 9 |
| ANTIBODIES TO MATRIX METALLOPROTEINASE 9 |